Kevin Lalande is the founding managing director and chief investment officer at Sante Ventures. He is a repeat founder and focuses on platform companies in drug discovery, with technical fluency in AI.
At firms with a similar stage, sector and check size.
One email when Kevin's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckKevin Lalande is the founding managing director and chief investment officer at Sante Ventures. He is a repeat founder and focuses on platform companies in drug discovery, with technical fluency in AI.
Kevin Lalande invests through Santé Ventures, which writes checks of $3M to $30M at seed, series a, series b.
Email [email protected], the firm's inbox for founders, and name Kevin in the subject. A warm intro from a founder Santé Ventures backed works better.
Founding Managing Director & Chief Investment Officer at Sante Ventures.
Last updated 2026-10-15. Is this you? Ask for a correction.